BlueDot

BlueDot is a Canadian infectious-disease intelligence company founded in 2013 by Dr. Kamran Khan. The company’s origin story is tied to the 2003 SARS outbreak in Toronto. Khan, then beginning his career as an infectious-disease physician at the University of Toronto, witnessed the outbreak’s effects on hospitals, the city’s social fabric, and the economy. BlueDot’s stated purpose is to use data and technology to help organizations get ahead of infectious-disease outbreaks. The company describes its work as combining human and artificial intelligence, with capabilities for surveillance, forecasting, and analysis of infectious diseases. Its stated aim is to help customers detect emerging threats, understand potential risks, and make timely decisions. BlueDot serves public-health organizations and governments, as well as clients in pharma and life sciences and global enterprises concerned with the effects of outbreaks on people, operations, supply chains, and reputation. BlueDot says it gained global recognition for detecting COVID-19 nearly a week before the World Health Organization. The company presents its offering as an always-on global disease-surveillance and intelligence system. The supplied sources identify Toronto, Canada, as the company’s location, but do not specify its ownership, listing status, or current leadership beyond founder Dr. Kamran Khan.

BlueDot was founded in 2013 by Dr. Kamran Khan. The company’s official account traces its motivation to the 2003 SARS outbreak in Toronto. Khan had begun his career as an infectious-disease physician at the University of Toronto when the outbreak disrupted hospitals, affected the city’s social fabric, and caused lasting economic damage. The experience led him to conclude that the world had entered a new era of epidemics. BlueDot’s founding premise is that infectious diseases can spread quickly across borders and disrupt communities and organizations, while modern data and computing capabilities can help produce useful insights more quickly. The company describes its approach as drawing on diverse data, machine learning, advanced analytics, cloud computing, and human expertise. It says its work spans surveillance to increase awareness and uncover blind spots, intelligence to forecast what may come next, and analysis to clarify the burden of infectious diseases. The company says it began with a public-health focus and expanded to serve enterprise clients in pharma, life sciences, and risk management. Its stated customer groups also include governments, public-health organizations, and global enterprises. BlueDot presents its services as helping customers detect emerging infectious-disease threats, assess risks to populations and business operations, and act in time to reduce disruption. BlueDot’s official story says that it gained global recognition when it detected COVID-19 nearly a week before the World Health Organization. The available sources establish the company’s 2013 founding, its Toronto connection, its founder, the outbreak-intelligence focus, and the customer sectors it describes. They do not provide details on ownership, financing, listings, acquisitions, or subsequent leadership changes.

• 2013

  BlueDot founded by Dr. Kamran Khan

  [2]Our Story - BlueDotbluedot.global
• 2003

  SARS outbreak in Toronto inspires the company’s founding mission

  [2]Our Story - BlueDotbluedot.global
• Company reports early detection of COVID-19

  [2]Our Story - BlueDotbluedot.global

An infectious-disease intelligence provider using human and artificial intelligence to help governments and enterprises identify, anticipate, and respond to outbreaks.

• Infectious-disease intelligence

  The company describes intelligence services that help customers detect emerging disease threats, assess risks, and respond.

• Global disease surveillance and intelligence system

  An always-on system presented for helping global enterprises build readiness and resilience against outbreaks.

• 2020.06.23

  Reported2020.06.23

  Toronto Pearson partners with BlueDot on infectious-disease risk monitoring[4]多伦多皮尔逊机场与 BlueDot 合作监测传染病风险mobilesyrup.com

  Toronto Pearson Airport partnered with data analytics firm BlueDot to predict and manage risks from COVID-19 and other infectious diseases.

Read more

1. 1BlueDot: The world's most trusted infectious disease intelligencebluedot.global
2. 2Our Story - BlueDotbluedot.global
3. 3BlueDot (Canada)wikidata.org
4. 4多伦多皮尔逊机场与 BlueDot 合作监测传染病风险mobilesyrup.com